HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem completes acquisition

This article was originally published in The Rose Sheet

Executive Summary

Chattem announces Jan. 2 it has closed its agreement to purchase, for $410 mil. in cash, the U.S. rights to five brands divested in connection with Johnson & Johnson's acquisition of Pfizer's Consumer Healthcare business, including anti-cavity mouthwash brand ACT (1"The Rose Sheet" Oct. 9, 2006, In Brief). "We are very excited to add these leading brands to the company's existing portfolio of quality products," Chattem CEO and Chairman Zan Guerry says. Chattem will replace Fidelity Bankshares in Standard & Poor's SmallCap 600 index after the close of trading Jan. 5...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS014444

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel